Search Results - "Mudigonda, Tejaswi"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Incidence, Risk Factors, and Preventative Management of Skin Cancers in Organ Transplant Recipients: A Review of Single‐ and Multicenter Retrospective Studies from 2006 to 2010 by Mudigonda, Tejaswi, Levender, Michelle M., O'Neill, Jenna L., West, Cameron E., Pearce, Daniel J., Feldman, Steven R.

    Published in Dermatologic surgery (01-03-2013)
    “…Background Organ transplant recipients (OTRs) taking immunosuppressants are at high risk of skin cancer, which is the most common malignant condition in OTRs,…”
    Get full text
    Journal Article
  2. 2

    A review of targeted ultraviolet B phototherapy for psoriasis by Mudigonda, Tejaswi, BS, Dabade, Tushar S., MD, Feldman, Steven R., MD, PhD

    “…Targeted ultraviolet (UV) B phototherapy devices provide a practical means to treat localized psoriasis while sparing harmful effects to unaffected skin. The…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    The economic impact of non-melanoma skin cancer: a review by Mudigonda, Tejaswi, Pearce, Daniel J, Yentzer, Brad A, Williford, Phillip, Feldman, Steven R

    “…Non-melanoma skin cancer (NMSC) is the most common cancer in the United States. Cost of NMSC care primarily depends on 2 factors: care settings and treatment…”
    Get more information
    Journal Article
  9. 9

    Postoperative Infections in Dermatologic Surgery: The Role of Wound Cultures by Ken, Kimberly M., Johnson, Mariah M., Leitenberger, Justin J., Neal, Donald E., Etzkorn, Jeremy R., Govas, Panayiota, Carroll, Bryan T., Badawi, Ahmed H., Mudigonda, Tejaswi, Council, M. Laurin, Avila, Christina, Carr, David R., Sasaki, Jodie, Blalock, Travis W., Golda, Nicholas J.

    Published in Dermatologic surgery (01-10-2020)
    “…BACKGROUNDDermatologic surgery is associated with low postoperative infection rates, averaging from approximately 1% to 4.25%. Often, postoperative infections…”
    Get full text
    Journal Article
  10. 10

    Palliative cancer care ethics: principles and challenges in the Indian setting by Mudigonda, Tejaswi, Mudigonda, Parvathi

    Published in Indian journal of palliative care (01-09-2010)
    “…Palliative cancer treatment is a system of care that seeks to relieve suffering in patients with progressive cancer. Given the intractable symptoms with which…”
    Get full text
    Journal Article
  11. 11

    Horrendous, Treatment-resistant Pediatric Atopic Dermatitis Solved With a Change in Vehicle by Mudigonda, Tejaswi, Kaufman, William, Feldman, Steven R

    Published in Journal of drugs in dermatology (01-01-2016)
    “…Severe atopic dermatitis can have an enormous impact on a child and the child's caregivers. Topical corticosteroids can be highly effective, but not all…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    A review of protocols for 308 nm excimer laser phototherapy in psoriasis by Mudigonda, Tejaswi, Dabade, Tushar S, Feldman, Steven R

    Published in Journal of drugs in dermatology (01-01-2012)
    “…308 nm excimer laser phototherapy is efficacious in the treatment of localized psoriasis. Different approaches regarding dose fluency, number of treatments,…”
    Get more information
    Journal Article
  16. 16

    Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis by Mudigonda, Parvathi, Mudigonda, Tejaswi, Feneran, Ashley N, Alamdari, Habibollah S, Sandoval, Laura, Feldman, Steven R

    Published in Dermatology online journal (15-10-2012)
    “…Emerging data in mice and humans reveals a critical contribution of Th17-associated cytokines, particularly interleukin-(IL)-23 and IL-17, in the pathogenesis…”
    Get full text
    Journal Article
  17. 17

    Therapeutic Modalities for Localized Psoriasis: 308-nm UVB Excimer Laser Versus Nontargeted Phototherapy by MUDIGONDA, Tejaswi, DABADE, Tushar S, WEST, Cameron E, FELDMAN, Steven R

    Published in Cutis (New York, N.Y.) (01-09-2012)
    “…UVB phototherapy is an effective treatment modality for psoriasis. For patients with localized plaque-type lesions, 308-nm excimer laser phototherapy offers…”
    Get full text
    Journal Article
  18. 18